Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer
Clinical trial NCT00721747 · UNKNOWN
Trial details
- NCT number
- NCT00721747
- Sponsor
- Grupo Oncológico Gallego
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-01-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.